Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, August 1998, p. 2024-2031, Vol. 42, No. 8
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Cloning and Nucleotide Sequences of the
Topoisomerase IV parC and parE Genes of
Mycoplasma hominis
Cécile M.
Bébéar,1,2
Alain
Charron,1
Joseph Marie
Bové,2
Christiane
Bébéar,1 and
Joel
Renaudin2,*
Laboratoire de Bactériologie,
Université Bordeaux 2, 33076 Bordeaux
Cedex,1 and
Laboratoire de Biologie
Cellulaire et Moléculaire, Institut National de la Recherche
Agronomique, 33883 Villenave d'Ornon Cedex,2
France
Received 26 January 1998/Returned for modification 12 May
1998/Accepted 8 June 1998
The topoisomerase IV parC and parE genes
from the wall-less organism Mycoplasma hominis PG21 were
cloned and sequenced. The coupled genes are located far from the DNA
gyrase genes gyrA and gyrB. They encode
proteins of 639 and 866 amino acids, respectively. As expected, the
encoded ParE and ParC proteins exhibit higher homologies with the
topoisomerase IV subunits of the gram-positive bacteria
Staphylococcus aureus and Streptococcus
pneumoniae than with their Escherichia coli
counterparts. The conserved regions include the Tyr residue of the
active site and the region involved in quinolone resistance (quinolone
resistance-determining region [QRDR]) in ParC and the ATP-binding
site and the QRDR in ParE.
*
Corresponding author. Mailing address: Laboratoire de
Biologie Cellulaire et Moléculaire, Institut National de la
Recherche Agronomique, Domaine de la Grande Ferrade, BP 81, 33883 Villenave d'Ornon Cedex, France. Phone: (33) 5 56 84 31 51. Fax:
(33) 5 56 84 31 59. E-mail: renaudin{at}bordeaux.inra.fr.
Antimicrobial Agents and Chemotherapy, August 1998, p. 2024-2031, Vol. 42, No. 8
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Pereyre, S., Renaudin, H., Charron, A., Bebear, C., Bebear, C. M.
(2006). Emergence of a 23S rRNA mutation in Mycoplasma hominis associated with a loss of the intrinsic resistance to erythromycin and azithromycin. J Antimicrob Chemother
57: 753-756
[Abstract]
[Full Text]
-
Pereyre, S., Gonzalez, P., de Barbeyrac, B., Darnige, A., Renaudin, H., Charron, A., Raherison, S., Bebear, C., Bebear, C. M.
(2002). Mutations in 23S rRNA Account for Intrinsic Resistance to Macrolides in Mycoplasma hominis and Mycoplasma fermentans and for Acquired Resistance to Macrolides in M. hominis. Antimicrob. Agents Chemother.
46: 3142-3150
[Abstract]
[Full Text]
-
Reinhardt, A. K., Kempf, I., Kobisch, M., Gautier-Bouchardon, A. V.
(2002). Fluoroquinolone resistance in Mycoplasma gallisepticum: DNA gyrase as primary target of enrofloxacin and impact of mutations in topoisomerases on resistance level. J Antimicrob Chemother
50: 589-592
[Abstract]
[Full Text]
-
Reinhardt, A. K., Bebear, C. M., Kobisch, M., Kempf, I., Gautier-Bouchardon, A. V.
(2002). Characterization of Mutations in DNA Gyrase and Topoisomerase IV Involved in Quinolone Resistance of Mycoplasma gallisepticum Mutants Obtained In Vitro. Antimicrob. Agents Chemother.
46: 590-593
[Abstract]
[Full Text]
-
Bébéar, C. M., Grau, O., Charron, A., Renaudin, H., Gruson, D., Bébéar, C.
(2000). Cloning and Nucleotide Sequence of the DNA Gyrase (gyrA) Gene from Mycoplasma hominis and Characterization of Quinolone-Resistant Mutants Selected In Vitro with Trovafloxacin. Antimicrob. Agents Chemother.
44: 2719-2727
[Abstract]
[Full Text]
-
Kenny, G. E., Young, P. A., Cartwright, F. D., Sjöström, K. E., Huang, W. M.
(1999). Ofloxacin Selects Gyrase Mutations in First-Step Mycoplasma hominis Mutants, whereas Sparfloxacin Selects Topoisomerase IV Mutations. Antimicrob. Agents Chemother.
43: 2493-2496
[Abstract]
[Full Text]
-
Bebear, C. M., Renaudin, J., Charron, A., Renaudin, H., de Barbeyrac, B., Schaeverbeke, T., Bebear, C.
(1999). Mutations in the gyrA, parC, and parE Genes Associated with Fluoroquinolone Resistance in Clinical Isolates of Mycoplasma hominis. Antimicrob. Agents Chemother.
43: 954-956
[Abstract]
[Full Text]